https://en.wikipedia.org/wiki/Ketamine#Depression
> The approval of esketamine for TRD by the FDA was controversial due to limited and mixed evidence of efficacy and safety.
> In January 2020, esketamine was rejected by the National Health Service (NHS) of Great Britain.[41] The NHS questioned the benefits of the medication for depression and claimed that it was too expensive.
https://en.wikipedia.org/wiki/Esketamine#Depression
It's too early, and it's for treatment resistant depression.
So yeah, unless you're a doctor/neurologist and know the protocol for validating drugs, it's not really worth listening to the pseudo science advocated by drug users who also encourage taking psilocybin/LSD/MDMA as a silver bullet, and constantly talk about pharma conspiracies. "Listen to the professionals" is a better advice.
0. https://link.springer.com/article/10.1007/s00213-014-3664-5
1. https://www.sciencedirect.com/science/article/abs/pii/S01650...